Wave Life Sciences (WVE) Current Leases (2015 - 2026)

Wave Life Sciences (WVE) has 11 years of Current Leases data on file, last reported at $3.5 million in Q2 2026.

• Quarterly Current Leases fell 56.88% year-over-year to $3.5 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $3.5 million (down 56.88% YoY) and the FY2025 annual result came in at $8.4 million, up 9.47% from the prior year.
• Current Leases eased to $3.5 million in Q2 2026, from $8.3 million in the prior quarter.
• In the past five years, Current Leases ranged from a high of $8.4 million in Q3 2025 to a low of $3.5 million in Q2 2026.
• A 5-year average of $6.6 million and a median of $6.8 million in 2023 frame the typical range for Current Leases.
• Annual changes were most pronounced in 2023 — Current Leases surged 44.05% — and 2026, when it tumbled 56.88%.
• Tracing WVE's Current Leases over 5 years: stood at $5.5 million in 2022, then increased by 22.16% to $6.7 million in 2023, then climbed by 13.76% to $7.6 million in 2024, then increased by 9.47% to $8.4 million in 2025, then tumbled by 58.04% to $3.5 million in 2026.
• The last three Current Leases figures came in at $3.5 million (Q2 2026), $8.3 million (Q1 2026), and $8.4 million (Q4 2025), per Business Quant data.